Blog
Make the Most of Your Retirement with These Top-Ranked Mutual Funds
It is never too late to invest in mutual funds for retirement. As such, if you plan to invest in some of the best funds, the Zacks Mutual Fund Rank can provide you with valuable guidance.
The best
Constellation Energy Corporation (CEG) Q3 Earnings Miss Estimates
Constellation Energy Corporation (CEG) came out with quarterly earnings of $3.04 per share, missing the Zacks Consensus Estimate of $3.13 per share. This compares to earnings of $2.74 per share a
3 Small-Cap Growth Mutual Funds to Buy for Impressive Returns
Small-cap funds generally invest in companies having a market cap of less than $2 billion. The companies, smaller in size, offer growth potential, and their market capitalization may increase
Brookfield Asset Management (BAM) Q3 Earnings and Revenues Top Estimates
Brookfield Asset Management (BAM) came out with quarterly earnings of $0.41 per share, beating the Zacks Consensus Estimate of $0.4 per share. This compares to earnings of $0.38 per share a year
Hanesbrands Q3 Earnings Miss Estimates, Sales Decline Y/Y
Hanesbrands Inc. (HBI) reported third-quarter 2025 results, wherein both top and bottom lines fell short of the Zacks Consensus Estimate. Revenues declined year over year. However, the bottom line
Yelp Stock Gains as Q3 Earnings and Revenues Surpass Estimates
Yelp Inc. YELP shares gained 2.5% during Thursday’s extended trading session after the company reported better-than-expected third-quarter 2025 results. The company’s third-quarter earnings
Atmus Filtration Technologies (ATMU) Tops Q3 Earnings and Revenue Estimates
Atmus Filtration Technologies (ATMU) came out with quarterly earnings of $0.69 per share, beating the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.61 per share a year
Look Beyond Growth: Buy These Value ETFs
Wall Street has been in a wavering mode lately, thanks to the concerns related to rich artificial intelligence (AI) valuations. Investors grew increasingly cautious amid mounting economic
EPAM Stock Gains 4% as Q3 Earnings and Revenues Beat Estimates
EPAM Systems, Inc. EPAM shares gained 4.4% on Thursday after the company released better-than-expected third-quarter 2025 results. EPAM reported third-quarter earnings of $3.08 per share, beating
TSM Stock Trades Near 52-Week High: Time to Hold or Book Profits?
Taiwan Semiconductor Manufacturing Company TSM, also known as TSMC, has had a remarkable run so far this year, with its shares soaring 46.5% year to date (YTD). The stock is benefiting from the AI
Graham (GHM) Q2 Earnings Lag Estimates
Graham (GHM) came out with quarterly earnings of $0.31 per share, missing the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.31 per share a year ago. These figures are
Camden's Q3 FFO Beat, Revenues Up Y/Y, '25 View Raised
Camden Property Trust CPT reported third-quarter 2025 core funds from operations (FFO) per share of $1.70, surpassing the Zacks Consensus Estimate of $1.69. However, the figure marginally declined
Essent Group (ESNT) Q3 Earnings Lag Estimates
Essent Group (ESNT) came out with quarterly earnings of $1.67 per share, missing the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.65 per share a year ago. These
CNH Industrial (CNH) Q3 Earnings Lag Estimates
CNH Industrial (CNH) came out with quarterly earnings of $0.08 per share, missing the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.24 per share a year ago. These
Hologic's Breast Health Rebounds, Takes Spotlight in Buyout Deal
Hologic HOLX exited the fourth quarter of fiscal 2025, achieving a turnaround for its Breast Health division. Revenues increased 4.8% to $393.7 million, mainly driven by strong sales of
Sanuwave Health Inc. (SNWV) Beats Q3 Earnings and Revenue Estimates
Sanuwave Health Inc. (SNWV) came out with quarterly earnings of $0.46 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to a loss of $6.49 per share a year ago. These
MarketAxess (MKTX) Surpasses Q3 Earnings and Revenue Estimates
MarketAxess (MKTX) came out with quarterly earnings of $1.84 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to earnings of $1.9 per share a year ago. These figures
USA Compression Q3 Earnings Beat Estimates, Revenues Rise Y/Y
USA Compression Partners USAC reported a third-quarter adjusted net profit of 26 cents per common unit, which beat the Zacks Consensus Estimate of 22 cents. The metric improved from the year-ago
Gray Media (GTN) Reports Q3 Loss, Beats Revenue Estimates
Gray Media (GTN) came out with a quarterly loss of $0.24 per share versus the Zacks Consensus Estimate of a loss of $0.41. This compares to earnings of $0.86 per share a year ago. These figures are
Rapid Micro Biosystems, Inc. (RPID) Reports Q3 Loss, Misses Revenue Estimates
Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.26 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.26 per share a year ago. These figures
Claritev Corporation (CTEV) Reports Q3 Loss, Tops Revenue Estimates
Claritev Corporation (CTEV) came out with a quarterly loss of $4.07 per share versus the Zacks Consensus Estimate of a loss of $3.12. This compares to a loss of $1.85 per share a year ago. These
AirSculpt Technologies, Inc. (AIRS) Reports Q3 Loss, Misses Revenue Estimates
AirSculpt Technologies, Inc. (AIRS) came out with a quarterly loss of $0.04 per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to a loss of $0.02 per share a year ago
Docebo Inc. (DCBO) Q3 Earnings and Revenues Beat Estimates
Docebo Inc. (DCBO) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.33 per share. This compares to earnings of $0.27 per share a year ago. These
Ares Commercial Real Estate (ACRE) Surpasses Q3 Earnings and Revenue Estimates
Ares Commercial Real Estate (ACRE) came out with quarterly earnings of $0.1 per share, beating the Zacks Consensus Estimate of a loss of $0.09 per share. This compares to earnings of $0.07 per share
Gyre Therapeutics, Inc. (GYRE) Q3 Earnings Surpass Estimates
Gyre Therapeutics, Inc. (GYRE) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.02 per share a year ago


